Rewire develops neuroscience‑backed digital therapeutics that use game‑based experiences to assess, strengthen, and repair neural pathways linked to depression and broader behavioural health.
Funding
Funding not disclosed
Founders
Product
Problem
Depression and other behavioral health conditions often lack objective, continuous monitoring tools, leading to delayed treatment adjustments and low patient adherence to traditional therapy regimens.
Solution
Rewire offers a digital therapeutic platform that combines neuroscience‑backed game experiences with passive biomarker collection to assess and strengthen neural pathways associated with depression. The games deliver evidence‑based interventions while continuously capturing data such as reaction times and engagement metrics, providing clinicians with real‑time insights between visits. This integration enables personalized care adjustments within existing clinical workflows, aiming to improve adherence and clinical outcomes without requiring additional hardware.
Target Audience
Primary customers are mental health clinicians, psychiatrists, and behavioral health clinics seeking digital tools to augment therapy for depression and related disorders.
Features
- Game-based interventions built on peer‑reviewed neural mechanisms targeting depression and broader behavioral health
- Continuous passive capture of digital biomarkers (e.g., performance metrics, usage patterns) for real‑time clinician monitoring
- Clinical‑grade data export that integrates with electronic health record systems and standard care pathways
- Adaptive difficulty and personalized feedback loops to reinforce targeted neural pathways
- Transdiagnostic design allowing use across multiple behavioral health conditions